These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 24157907)
1. Cell-to-cell vs. cell-free HIV-1 transmission from macrophages to CD4+ T lymphocytes: lessons from the virology textbook. Poli G AIDS; 2013 Sep; 27(14):2307-8. PubMed ID: 24157907 [No Abstract] [Full Text] [Related]
2. Antiviral treatments over cell-to-cell infection: is it just a matter of dose? Moris A AIDS; 2013 Sep; 27(15):2481-3. PubMed ID: 24029736 [No Abstract] [Full Text] [Related]
3. High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy. Duncan CJ; Russell RA; Sattentau QJ AIDS; 2013 Sep; 27(14):2201-6. PubMed ID: 24005480 [TBL] [Abstract][Full Text] [Related]
4. Both CD31(+) and CD31⁻ naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. Wightman F; Solomon A; Khoury G; Green JA; Gray L; Gorry PR; Ho YS; Saksena NK; Hoy J; Crowe SM; Cameron PU; Lewin SR J Infect Dis; 2010 Dec; 202(11):1738-48. PubMed ID: 20979453 [TBL] [Abstract][Full Text] [Related]
5. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023 [TBL] [Abstract][Full Text] [Related]
7. Immuno-Pharmacological Targeting of Virus-Containing Compartments in HIV-1-Infected Macrophages. Graziano F; Vicenzi E; Poli G Trends Microbiol; 2016 Jul; 24(7):558-567. PubMed ID: 27012511 [TBL] [Abstract][Full Text] [Related]
8. Efficient transfer of HIV-1 in trans and in cis from Langerhans dendritic cells and macrophages to autologous T lymphocytes. Peressin M; Proust A; Schmidt S; Su B; Lambotin M; Biedma ME; Laumond G; Decoville T; Holl V; Moog C AIDS; 2014 Mar; 28(5):667-77. PubMed ID: 24451159 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages. Benjouad A; Seddiki N; Ylisastigui L; Gluckman JC AIDS Res Hum Retroviruses; 1997 Feb; 13(3):219-26. PubMed ID: 9115808 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anti-retroviral activity of the substance purified from the aqueous extract of Chelidonium majus L. Gerencer M; Turecek PL; Kistner O; Mitterer A; Savidis-Dacho H; Barrett NP Antiviral Res; 2006 Nov; 72(2):153-6. PubMed ID: 16647765 [TBL] [Abstract][Full Text] [Related]
11. The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets. Flynn JK; Paukovics G; Moore MS; Ellett A; Gray LR; Duncan R; Salimi H; Jubb B; Westby M; Purcell DF; Lewin SR; Lee B; Churchill MJ; Gorry PR; Roche M Virology; 2013 Jul; 442(1):51-8. PubMed ID: 23602007 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies. Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601 [TBL] [Abstract][Full Text] [Related]
13. New treatment a cure? Moment of truth draws nigh. AIDS Alert; 1997 Aug; 12(8):90-2. PubMed ID: 11364474 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse. Ao Z; Huang J; Tan X; Wang X; Tian T; Zhang X; Ouyang Q; Yao X J Virol Methods; 2016 Feb; 228():95-102. PubMed ID: 26640121 [TBL] [Abstract][Full Text] [Related]
16. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. Streeck H; Jessen H; Alter G; Teigen N; Waring MT; Jessen A; Stahmer I; van Lunzen J; Lichterfeld M; Gao X; Allen TM; Carrington M; Walker BD; Rockstroh JK; Altfeld M J Infect Dis; 2006 Sep; 194(6):734-9. PubMed ID: 16941338 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages. Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903 [TBL] [Abstract][Full Text] [Related]
18. Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4(+) T cells. Kok YL; Vongrad V; Shilaih M; Di Giallonardo F; Kuster H; Kouyos R; Günthard HF; Metzner KJ Sci Rep; 2016 Apr; 6():24157. PubMed ID: 27067385 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 in Monocytes and Macrophages: An Overlooked Reservoir? Hassan J; Browne K; De Gascun C Viral Immunol; 2016 Nov; 29(9):532-533. PubMed ID: 27564791 [No Abstract] [Full Text] [Related]
20. The nef gene controls syncytium formation in primary human lymphocytes and macrophages infected by HIV type 1. Meylan PR; Baumgartner M; Ciuffi A; Munoz M; Sahli R AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1531-42. PubMed ID: 9840286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]